This article has been disseminated on behalf of ShelfieTech Ltd. (CSE: SHLF) (OTCQB: SHLFF) and may include paid advertising.

• ShelfieTech’s corporate update highlights a strengthened financial position through recently completed financing rounds.
• Another significant milestone is the completion of the company’s dual listing on both the CSE and the OTCQB market.
• ShelfieTech has reached a foundational milestone by concluding the first stage of research and development for its Robotic Retail Shelf Monitoring System.

Retail technology innovators that can turn research progress into market-ready solutions often attract strong attention, especially when they achieve tangible milestones that move them closer to wide adoption. In a recent corporate update, ShelfieTech (CSE: SHLF) (OTCQB: SHLFF) outlines a series of accomplishments in 2025 that reflect both strategic execution and momentum in deploying its next-generation retail automation technology. From financing success to dual exchange listings and product development advancements, the company’s update highlights a year of meaningful corporate progress.

ShelfieTech’s corporate update highlights the company’s strengthened financial position through recently completed financing rounds that add depth to its balance sheet. Earlier this month, the company closed a private placement that raised approximately $1.7 million, bringing the total capital raised this year to about $3.4 million when combined with its earlier financing prior to listing on the Canadian Securities Exchange (“CSE”).

The influx of capital is intended to support the continued development of the company’s technology platform, potential synergistic acquisitions and general working capital as it enters new phases of growth. This financial backing gives the company increased flexibility as it prepares for commercial deployment of its offerings, reflecting investor confidence in its strategy and long-term prospects.

Another significant milestone ShelfieTech reported is the completion of its dual listing on both the CSE under the symbol SHLF and the OTCQB market in the United States under the symbol SHLFF. Dual listing can help broaden investor access, improve tradability and elevate the company’s visibility across multiple capital markets. For emerging technology firms, achieving multiple exchange listings can serve not only as a validation of their public company governance and reporting commitments but also as a platform to attract a more diverse investment base. This expanded market presence aligns with the company’s goal of securing the resources and recognition necessary to scale its retail technology solutions.

In terms of product development, ShelfieTech has reached a foundational milestone by concluding the first stage of research and development for its Robotic Retail Shelf Monitoring System. This robotic platform, designed to automate the capture of shelf-level data and enable more accurate, real-time visibility of in-store conditions, marks a key innovation in the company’s technology roadmap. With this stage complete, ShelfieTech plans to begin beta installations in supermarket environments, a crucial step that will allow the company to validate system performance in real-world settings and collect operational data ahead of broader commercial rollout.

Beyond the hardware phase, the company’s update describes a shift toward enhanced AI-driven capabilities that extend the utility of its platform. In the next phase of development, ShelfieTech plans to accelerate work on advanced AI-powered logistics tools, sophisticated inventory analytics and intelligent store-management systems. By incorporating machine learning and data analytics modules into the platform, the company intends to transform raw in-store data into actionable decision support and predictive insights. This evolution positions ShelfieTech not just as a hardware provider but also as a software-centric technology partner for retailers seeking deeper automation and operational intelligence.

These achievements reflect a company moving methodically toward its strategic goals while laying the groundwork for future commercial activity. ShelfieTech’s emphasis on both technology maturation and financial readiness helps demonstrate its commitment to transitioning from development to deployment.

The beta stage of the robotic shelf monitoring system will be particularly important for showcasing the practical value of ShelfieTech’s solutions to potential retail customers and partners. This phase typically provides insights into performance across different store formats and use cases, enabling fine-tuning before a full commercial launch.

The strategic decision to expand into software-centric tools speaks to ShelfieTech’s understanding of evolving retailer needs. As retailers increasingly seek automation that delivers not only data but also context and advanced analytics, the ability to offer a suite of integrated insights becomes a key differentiator. Sophisticated inventory analytics and operational decision support tools can help store managers anticipate trends, optimize stock levels and allocate resources more effectively, all of which contribute to improved efficiency and customer satisfaction.

ShelfieTech’s milestone achievements represent a year of building strength from the inside out: securing capital, formalizing market presence through dual listings and advancing key technology toward commercial readiness. As the company moves forward into 2026, the outcomes of its beta installations and the maturity of its AI-driven systems will be closely watched by industry observers and retail partners alike. With each step forward, ShelfieTech brings its vision of automated retail operations and intelligent store management closer to reality, supporting its long-term goal of enhancing in-store performance through innovation.

For more information, visit www.ShelfieTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SHLFF are available in the company’s newsroom at https://ibn.fm/SHLFF

• U.S. and global electricity demand is rising sharply, driven in part by energy-hungry AI-focused data centers.
• Safe & Green Holdings operates across oil and gas production, services, and energy technologies, as energy independence has returned to the policy and investment agenda in the United States.
• Wholly owned subsidiary Olenox gives Safe & Green Holdings exposure to domestic energy supply and significant service revenues.
• Digital monitoring and optimization tools are increasingly important in modern energy operations.

U.S. electricity consumption is set to reach record levels in 2025 and 2026, according to projections from the Energy Information Administration. The agency expects demand to climb to 4,199 billion kilowatt-hours in 2025 and 4,267 billion kWh in 2026, up from a record 4,110 billion kWh in 2024, as reported by Reuters in December (https://ibn.fm/oZz7s).

A significant driver of that increase is the rapid expansion of data centers dedicated to artificial intelligence and high-performance computing. These facilities consume large amounts of electricity around the clock, adding pressure to power grids already adapting to electrification in transport, heating, and industry. For investors, this shift is refocusing attention on companies positioned to supply energy reliably while improving efficiency and monitoring.

Safe & Green Holdings (NASDAQ: SGBX), a diversified holding company, through its vertically integrated energy operations, is one of the smaller public companies seeking to align itself with these structural trends. Following the February 2025 merger of SGBX and Olenox, the company consolidated its energy activities under Olenox Corp., a wholly owned subsidiary focused on domestic production, services, and energy technologies.

The broader backdrop is not limited to the United States. The International Energy Agency reported that global energy demand grew by 2.2% in 2024, nearly twice the average rate seen over the past decade, with electricity consumption rising by 4.3% year over year (https://ibn.fm/SJ9YO). The IEA cited data centers, AI workloads, industrial electrification, and record temperatures as key contributors.

This renewed growth has reversed years of declining energy consumption in advanced economies. It has also reinforced the role of natural gas and oil alongside renewables and nuclear, particularly as grids seek reliability to support continuous data processing. For companies like Safe & Green, the emphasis on American energy independence and domestic supply chains has become more than a political talking point; it is increasingly a commercial consideration.

Olenox’s Oil and Gas division operates in Texas, Oklahoma, and Kansas, focusing on acquiring neglected or distressed properties with remaining production potential. Rather than pursuing frontier exploration, the strategy centers on extracting additional value from existing assets. In an environment where incremental supply matters, especially during demand spikes from data centers, such assets can contribute to domestic energy availability without long lead times.

Complementing production, Olenox’s Oilfield Services division provides abandonment and environmental reclamation services for third parties. This business generates an additional cash flow stream and supports the production arm with well services.

Olenox’s technologies division adds another layer. Olenox has developed proprietary plasma pulse and ultrasonic cleaning tools designed to recondition and stimulate underperforming wells. These tools aim to extend the productive life of existing infrastructure, an approach that aligns with the need to maximize output from current assets rather than relying solely on new drilling.

Beyond hydrocarbons, Safe & Green has emphasized digital oversight of energy operations. The company works with Machfu, a wholly owned subsidiary of Olenox, to deploy edge-to-enterprise devices that connect industrial field assets to secure cloud platforms. These systems provide real-time monitoring of equipment and production, allowing operators to respond quickly to performance issues or maintenance needs.

Such monitoring capabilities are increasingly relevant as energy systems grow more complex. Data centers require not only large volumes of electricity but also high reliability. Any disruption can be costly. While Safe & Green is not a power utility, its focus on monitoring, optimization, and efficiency reflects a broader shift in the energy sector toward data-driven operations.

The macro data underscores why these themes matter. Reuters noted that U.S. commercial power sales are expected to reach 1,486 billion kWh in 2025, surpassing previous highs, while residential and industrial consumption also remain elevated. At the same time, the EIA projects renewables will increase their share of generation, but natural gas will continue to play a central role in balancing the grid.

The IEA’s analysis points to a similar global pattern. While renewables and nuclear accounted for roughly 80% of the increase in electricity generation in 2024, natural gas demand rose by 2.7%, the strongest growth among fossil fuels. This reflects the need for flexible, dispatchable power to support intermittent renewables and continuous loads like AI data centers.

Safe & Green’s alignment with American energy independence is of critical importance. Domestic oil and gas production, combined with services that maintain and optimize existing wells, fits into a policy environment focused on supply security. The company’s ownership of New Asia Holdings and its integrated structure following the Olenox merger simplify that positioning to several intersecting trends: rising electricity demand driven by AI, renewed emphasis on domestic energy supply, and the growing use of digital tools to manage energy assets.

For more information, visit the company’s website at www.SafeandGreenHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to SGBX are available in the company’s newsroom at https://ibn.fm/SGBX

Disseminated on behalf of  ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

• ESGold Corp., an exploration-stage company committed to the acquisition, exploration, and development of high-quality mineral properties worldwide, just closed its non-brokered private placement of follow-through common shares, for aggregate gross proceeds of $4,505,000
• These proceeds will help fund the exploration of its Montauban property in Quebec
• ESGold also engaged Atrium Research Corporation for research and publication of various reports on the investment case for ESGold, with services to run for 12 months

ESGold (CSE: ESAU) (OTCQB: ESAUF), an exploration-stage company committed to acquiring, exploring, and developing high-quality mineral properties worldwide, just announced the closing of its non-brokered private placement of follow-through common shares for aggregate gross proceeds of $4,505,000. The closing came just a few weeks after the company announced its intention to proceed with the private placement, tasking Red Cloud Securities Inc. as a finder in connection with the offering (https://ibn.fm/2NHRq).

In total, 5,300,000 shares were transacted at $0.85 per FT share, with Red Cloud Securities Inc. receiving an aggregate cash finder’s fee of $315,350. With the earnings, ESGold looks to fund exploration on its Montauban property in Quebec. The expenses are defined in paragraph (f) of the definition of “Canadian exploration expense” in subsection 66.1(6) of the Income Tax Act (Canada). They will qualify as “flow-through mining expenditures, incurred on or before December 31, 2026.

This milestone places ESGold in an advantageous position, with the resources to explore such a valuable mining site and a runway that aims to bring the company close to monetization and profitability much sooner than most of its competitors. It places it ahead of the curve, particularly as it works to stamp its position as a leader in its space.

The Montauban property has shown incredible potential from recent exploration activities and initiatives. For the company’s comprehensive three-dimensional geological model analysis of the property, it was noted that the property is not just a reclamation or redevelopment story, but rather the nucleus of a potentially much larger gold, silver, and base-metal district, which is a huge discovery for the company (https://ibn.fm/D8zCg). It shows just how much value the property holds. It also emphasizes the need to fast-track its further exploration and extraction of value, not just to place the company ahead of other players in its space, but also to grow shareholder value.

ESGold has also engaged Atrium Research Corporation, a leading company-sponsored research firm. Atrium will be responsible for researching and publishing various reports on ESGold based on publicly available information, discussions with the company’s management, and industry data. In addition, it will host three recorded interviews with ESGold’s management to present the investment case (https://ibn.fm/h1ZLh).

Atrium will receive a cash compensation of $12,000 per quarter for these services, which kicked off on December 15, 2025, and will run for 12 months. It provides a platform for ESGold and its management to share their vision, update interested parties on their progress and offer a first-hand account of how the industry is evolving. For investors, it will also be an additional avenue to keep tabs on what the company is doing, the decisions the management is making, and where it is headed overall.

Neither Atrium nor its insiders hold any shares or options to purchase shares in ESGold’s capital. The two are just arm’s-length parties, with their engagement subject to regulatory and Canadian Securities Exchange approval.

For company information, visit the company’s website at www.ESGold.com.

NOTE TO INVESTORS: The latest news and updates relating to ESAUF are available in the company’s newsroom at https://ibn.fm/ESAUF

• Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events identified during the treatment period.
• An optimized gel formulation was designed to improve the patient experience, with both easier dispensation and skin application.
• SGX302 utilizes visible light-activated synthetic hypericin, a first-in-class photodynamic therapy mechanism.

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products for rare diseases where unmet medical need exists, announced extended top line results from its Phase 2a clinical trial of SGX302 (synthetic hypericin) in patients with mild-to-moderate psoriasis. The updated findings highlight clinical improvements with an optimized gel formulation of the investigational therapy, underscoring the potential of SGX302 as a noncarcinogenic, photodynamic treatment.

According to the company, the Phase 2a trial has progressed into an extension cohort (cohort 3) that enrolled an additional four patients treated with an improved topical gel formulation of SGX302. SGX302 gel was applied to psoriasis lesions twice a week over an 18-week period, the same duration as prior cohorts in the study. The gel formulation was designed to improve ease of application, particularly for larger or more extensive areas of affected skin.

Soligenix reported that SGX302 was well tolerated by all patients in cohort 3, with no drug-related adverse events identified during the treatment period. Among the three evaluable patients (one patient discontinued for personal reasons unrelated to the therapy), improvements were observed across multiple clinical measures. Measures used included the Investigator Global Assessment (“IGA”) and the Psoriasis Activity and Severity Index (“PASI”), standard scales used in dermatology to quantify disease severity and response to treatment.

One patient reached a disease status categorized as “Almost Clear” on the IGA scale, which is widely regarded as a marker of meaningful clinical success in psoriasis studies. This was accompanied by a substantial PASI improvement exceeding 50%, a benchmark that developers and clinicians consider evidence of therapeutic effect in skin disease trials. The outcomes seen with the optimized gel formulation were described as similar to or improved relative to prior responses seen with earlier SGX302 ointment formulation, consistent with expectations given the comparable release characteristics of the drug and the improved ease of application inherent to the gel.

“We are pleased with the preliminary findings from our ongoing Phase 2a trial,” said Soligenix president and CEO Christopher J. Schaber. “The optimized gel formulation was designed to improve the patient experience, with both easier dispensation and skin application. The expansion of this psoriasis study continues our evaluation of synthetic hypericin into other disease indications, including non-orphan indications, where there remains an unmet medical need.” Schaber also emphasized that the expansion of the psoriasis study continues the company’s evaluation of synthetic hypericin in indications beyond those historically targeted, addressing disease settings with large populations and significant unmet needs.

Current estimates show as many as 60 million to 125 million people worldwide living with psoriasis, a chronic inflammatory skin disease that can greatly impact quality of life. Psoriasis was projected to represent a global treatment market valued at approximately $15 billion in 2020, with forecasts suggesting the market could reach as much as $40 billion by 2027.

SGX302 utilizes visible light-activated synthetic hypericin, a first-in-class photodynamic therapy mechanism. Unlike some traditional photodynamic therapies that activate with ultraviolet (“UV”) light, which can be associated with DNA damage and long-term safety concerns, SGX302’s use of the red-yellow spectrum of visible light may provide deeper tissue penetration and a safer profile. The therapy works by absorbing visible light to induce apoptosis (programmed cell death) in target cells, addressing the underlying dysregulated immune activity in psoriasis lesions. This mechanism is conceptually similar to that observed in the positive Phase 3 FLASH study of synthetic hypericin in cutaneous T-cell lymphoma.

The ongoing Phase 2a study has enrolled sequential cohorts, each treated over an 18-week regimen. In cohort 1, five patients were treated with a 0.25% SGX302 ointment formulation applied twice weekly, followed by visible light activation approximately 24 hours later. While the initial cohort demonstrated biological signal and generally tolerated therapy well with improvements in PASI scores, none of the cohort reached a predefined clinical success threshold (IGA score of 0 or 1) by week 18 under the original dosing protocol.

Based on safety and tolerability observed in cohort 1, the second cohort was enrolled with an accelerated visible light dosing schedule allowing higher doses to be reached earlier in the treatment cycle. Among the four evaluable patients in cohort 2, two achieved clinical success at some point during the 18-week period and all demonstrated improvement, averaging about a 50% reduction in PASI score, further validating the biological activity of SGX302 across formulations and dosing strategies.

Soligenix’s SGX302 program is part of the company’s broader pipeline exploring synthetic hypericin in both rare and more common disease indications. In addition to mild-to-moderate psoriasis, synthetic hypericin is also being pursued under the name HyBryte(TM) in late-stage development for cutaneous T-cell lymphoma (“CTCL”), an orphan dermatologic cancer with high unmet need. A confirmatory Phase 3 study of HyBryte continues to advance, and topline results are expected as part of the company’s clinical roadmap in 2026.

The positive data from cohort 3 support continued development of SGX302 as a noncarcinogenic, nonmutagenic photodynamic therapeutic. The demonstrated improvements in clinical endpoints and quality of life measures with the optimized gel form reinforce the potential for the therapy to expand into commercial development pathways, especially if confirmatory Phase 3 trials replicate and extend these early results.

As psoriasis remains a prevalent chronic disease with limited curative options, the announcement of these extended Phase 2a results represents a meaningful milestone for Soligenix and an important step forward in the broader validation of synthetic hypericin as a therapeutic platform. With data indicating improved application characteristics, strong tolerability and clear biological signals of efficacy, the company is poised to pursue further clinical advancement while navigating regulatory and commercial strategy in indications with significant unmet patient need.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

• A recent report from India is a stark reminder of ricin’s accessibility and the pressing need for effective countermeasures.
• Ricin is a potent toxin capable of causing death within days of exposure because it stops protein synthesis inside cells, leading to organ failure.
• Soligenix has demonstrated meaningful preclinical efficacy for its ricin vaccine candidate.

A recent “Times of India” report spotlighted the danger posed by ricin, a highly toxic plant-derived compound with no known antidote and a history of attempted misuse by extremist actors. Soligenix (NASDAQ: SNGX), a biopharmaceutical company focused on biodefense solutions, is developing a vaccine candidate known as RiVax(R) to protect against ricin exposure, positioning the company’s work at the center of biodefense preparedness as public awareness of ricin’s lethality grows.

In a counter-terrorism operation in India, authorities recently foiled a ricin plot, underscoring how easily accessible castor beans can be transformed into the deadly toxin using common tools such as a coffee grinder. The report is a stark reminder of ricin’s accessibility and the pressing need for effective countermeasures. Ricin is derived from the castor oil plant (Ricinus communis) and has been used in previous plots, including a 2018 incident in Germany where a couple manufactured ricin from castor seeds at home, illustrating that ricin’s danger extends beyond laboratory settings and into real-world security concerns.

Ricin is a potent toxin capable of causing death within days of exposure because it stops protein synthesis inside cells, leading to organ failure. The U.S. Centers for Disease Control and Prevention notes that there is currently no cure for ricin poisoning, and treatment is limited to supportive care such as respiratory support and fluids to manage symptoms. Ricin’s lethality is well documented; inhalation, ingestion or injection can all trigger severe systemic effects, and even small exposures are dangerous.

Because no targeted treatment exists, the public health and biodefense communities classify ricin as a serious biological threat. The toxin’s stability, ease of manufacture and high toxicity make it of concern to national security agencies. CDC and similar authorities designate ricin a level B biothreat with potential uses in bioterrorism. The “Times” article reinforces that these risks are not merely theoretical; law enforcement around the world continues to intercept ricin-related threats, highlighting the real-world urgency of effective countermeasures.

Soligenix has demonstrated meaningful preclinical efficacy for RiVax in animal models. Data show that the vaccine has provided up to 100% protection in mice and nonhuman primates (“NHPs”) exposed to lethal doses of ricin toxin delivered systemically or by aerosol, a route considered most dangerous for human exposure. Thermostabilization of RiVax using Soligenix’s ThermoVax(R) technology enables the vaccine to withstand elevated temperatures, a key attribute for biodefense stockpiles that may be stored outside stringent cold-chain environments. The vaccine also has shown extended protection, with vaccinated animals surviving lethal challenge long after immunization.

Further supporting its development, RiVax has earned regulatory recognitions. The U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the vaccine, a status intended to expedite the development and review of medical countermeasures addressing serious conditions. Additionally, RiVax has received Orphan Drug designation in both the United States and Europe, reflecting its potential importance as a medical countermeasure for a rare but high-impact threat.

In addition to its ricin vaccine work, Soligenix’s broader public health solutions business segment includes other high-priority biologics and vaccine candidates targeting emerging pathogens. The company leverages ThermoVax technology to enhance the stability of multiple vaccine formats, addressing the logistical challenges associated with cold-chain storage that hamper rapid response and stockpile management.

The threat of ricin plots arising from seemingly mundane materials highlights the gap in available countermeasures for such biological toxins. The absence of an antidote and the extreme toxicity inherent to ricin underscore the need for preparedness solutions beyond traditional therapeutic approaches. In this context, a proven vaccine capable of preventing systemic effects from ricin exposure represents a significant public health and biodefense advantage.

RiVax’s durability, evidenced by thermostability and strong protective efficacy in animal models, could allow for strategic stockpiling in national stockpiles and rapid deployment to first responders, military personnel and vulnerable civilian populations should a ricin incident occur. Continued development and regulatory progression of the vaccine may also inform broader strategies for biodefense and emergency readiness in a world where accessible biological threats continue to challenge health security systems.

For more information, visit www.Soligenix.com.

NOTE TO INVESTORS: The latest news and updates relating to SNGX are available in the company’s newsroom at https://ibn.fm/SNGX

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.

• The field exploration program generated a substantial geological, geochemical, and radiometric dataset across multiple target areas.
• Mapping identified granitic and pegmatitic units considered favorable hosts for rare earth element mineralization.
• Radiometric surveys returned elevated readings that warrant further investigation, with pending assay results from 426 samples expected to guide next exploration steps.
• The companies increasing progress aligns with rising investor focus on securing non-Chinese rare earth supply chains.

Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company, has completed its 2025 field exploration program at the Atikokan Rare Earth Elements property, marking a key technical milestone as the company advances its portfolio of REE-focused assets. The property is located in the Atikokan–Ignace–White Otter Lake district of northwestern Ontario, a region with established infrastructure and a history of mineral exploration.

Details of the completed program were outlined in a December 17, 2025, announcement which described a systematic exploration campaign designed to evaluate the geological and geochemical potential of the Atikokan property. The 2025 field program combined geological mapping, prospecting, ground-based radiometric surveys, and geochemical sampling across several priority target areas (https://ibn.fm/BaIsZ).

In total, 426 samples were collected, including quality assurance and quality control material. The sample set comprised 251 soil samples, 10 sediment samples, and 165 rock samples, providing broad coverage of both outcropping and overburden-covered areas.

Geological mapping identified three principal lithological domains across the property. Block A is dominated by granodiorite to granite, while Block B consists mainly of gneissic tonalite, with granodiorite and granite appearing in its northern portion. Block C is also largely gneissic tonalite, with granodiorite and granite becoming more prominent toward the north-northeast.

Granitic and pegmatitic rocks are commonly associated with late-stage magmatic processes, during which incompatible elements such as rare earths can become concentrated. By contrast, gneissic tonalite is generally viewed as less prospective unless it has been overprinted by later intrusions or fluid-driven alteration.

Powermax reported the presence of granitic and pegmatitic units across parts of the Atikokan property, which management considers a favorable geological indicator. While the company cautioned that there is no assurance of economic mineralization, the mapping results provide a framework for prioritizing future sampling and drill targets.

Radiometric surveying was another central component of the 2025 program. These surveys measure natural gamma radiation, reported in counts per second, which can reflect the presence of potassium, thorium, and uranium, elements that frequently occur alongside REEs in granitic and pegmatitic systems.

Background radiometric levels in gneissic tonalite typically ranged from 60 to 80 cps, considered low in a regional context. However, where pegmatite bands and pods were present within tonalite, readings increased to approximately 250 to 400 cps. Granitic and granodioritic units returned higher values overall, ranging from about 100 to as high as 2,700 cps, with the strongest responses recorded in pegmatitic zones.

From an exploration standpoint, readings above 200–300 cps are often viewed as anomalous in granitoid terrains, while values exceeding 500 cps generally justify closer follow-up. The elevated responses observed at Atikokan therefore support continued geological and geochemical evaluation.

The ground program complements a high-resolution helicopter-borne magnetic and radiometric survey that Powermax has already completed over the property. The company is awaiting final interpretation from the survey contractor, which will integrate airborne geophysical data with the 2025 field results. Management expects this integrated dataset to help refine structural controls, prioritize anomalies, and shape the next phase of exploration.

All samples collected during the program were transported under chain-of-custody procedures to AGAT Laboratories in Calgary, an ISO/IEC 17025-accredited facility, for multi-element geochemical analysis. Assay results have not yet been released and will be a near-term focus for investors assessing the project’s potential.

Chief Executive Officer Paul Gorman described the program as a foundational step for the Atikokan asset, noting that the scale and systematic approach have produced a robust technical dataset to support evaluation of both rare earth and critical metals potential.

The work at Atikokan takes place against a broader backdrop of rising strategic interest in rare earth elements. Global demand is projected to grow sharply, driven by electric vehicles, wind power, and defense applications. At the same time, supply chains remain heavily concentrated in China, which controls a majority of mining and processing capacity.

Powermax is positioning its portfolio to align with these trends. In addition to Atikokan, the company holds options on the Cameron REE Property in British Columbia and the Pinard REE Property in northern Ontario, and owns a 100% interest in the Ogden Bear Lodge Project in Wyoming.

For more information, visit the company’s website at www.PowermaxMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to PWMXF are available in the company’s newsroom at https://ibn.fm/PWMXF

• The algorithm outlined in the patent application describes an approach to enhancing the detection precision and accuracy of AI when used to detect small objects in drone imagery.
• This patent filing is the latest in the company’s IP portfolio which includes other awarded and filed patents.
• Safe Pro Group has expanded international filings to protect the company’s IP rights in several countries and jurisdictions.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-powered security and defense solutions, recently announced the filing of the company’s most recent patent application (https://ibn.fm/G982Q).

The patent is for Safe Pro’s AI-powered computer vision technology that helps to rapidly and autonomously detect small explosive threats in drone-based videos and images. The patent, titled “Object Detection Precision Enhancement Methods, Tools and Systems,” outlines an algorithm that details an approach to enhancing the detection precision and accuracy of AI when used to detect small objects in drone images.

This approach to analyzing these drone images has already shown improved effectiveness over traditional methods in wide-scale operations where rapid analysis and processing is required. Safe Pro will be highlighting these enhanced capabilities at numerous upcoming events with the U.S. Army.

Speaking about the company’s technology, Chairman and CEO of Safe Pro Group Inc., Dan Erdberg, said that “Our AI team continues to rapidly enhance our unique AI-powered computer vision technology, greatly improving the accuracy of threat detection, capabilities built on growing real-world data and usage. The result is a leap in precision and operational reliability for large-scale missions that depend on trustworthy object detection, from landmine clearance to broader security and inspection applications.”

Safe Pro’s current IP portfolio includes the awarded US Patent No. 12,146,729, which incorporates 21 claims made in the company’s original patent application titled, “Systems and Methods for Detecting and Identifying Explosives.” This patent is valid until 2043 and captures the ground-breaking nature of the company’s SpotlightAI(TM) platform and how it can transform the humanitarian, demining, agriculture, and defense industries.

The company has also expanded international filings by entering into the national phase of a previously filed international application that it filed with the World Intellectual Property Organization (“WIPO”) in Europe, Canada, Australia, Japan, New Zealand, Ukraine, and Israel. Recently, the company also took a step towards acquiring international IP protection as it received notice of official publication of the company’s application in Europe, Australia, and Israel.

About Safe Pro Group Inc. (NASDAQ: SPAI)

Safe Pro Group is a tech company that delivers advanced AI-driven solutions in the defense and security industries. At the heart of the company’s mission is a patented computer vision software technology that is used to detect and identify small objects, such as landmines and other unexploded ordnance (“UXO”), in drone-based imagery and videos.

For more information, visit the company’s website at www.SafeProGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SPAI are available in the company’s newsroom at https://ibn.fm/SPAI

• Chairman and CEO Moishe Gubin used his NobleCon21 presentation to outline Strawberry Fields REIT’s disciplined expansion strategy and long-term approach to healthcare real estate.
• The company now holds long-term leasehold interests in 142 healthcare facilities with more than 15,500 licensed beds across 10 states.
• Gubin emphasized a conservative acquisition philosophy, with each property evaluated from an operator’s perspective despite the company’s role as a self-administered REIT.
• The REIT has consistently collected 100% of rents and maintains long-term triple-net leases with 3% annual increases.
• Third-quarter 2025 results showed continued momentum, including rental income of $39.7 million and AFFO of $18.1 million.
• The company maintains a payout ratio below 50%, allowing retained cash flow to fund acquisitions and support long-term AFFO growth.

Strawberry Fields REIT (NYSE American: STRW), a self-administered real estate investment trust specializing in healthcare-related properties, recently attended NobleCon21, where it reinforced how key concepts of disciplined acquisition, predictable cash flow, and long-term stability form the core of its strategy. Speaking at the annual growth event hosted by Noble Capital Markets, Chairman and CEO Moishe Gubin described a methodical expansion approach that has allowed the company to build one of the larger skilled-nursing-focused real estate portfolios in the United States (https://ibn.fm/62vC3).

The company concentrates on the acquisition, and leasing of skilled nursing and other healthcare-related properties. It does not develop or operate the facilities it owns. Instead, Strawberry Fields enters long-term triple-net leases with skilled operators, a structure that places operating costs, maintenance, taxes, and insurance obligations on the tenant while delivering predictable rental income to the REIT.

Gubin noted that the company’s portfolio has expanded significantly since 2015, when it spun out with 33 properties concentrated in Indiana and Illinois. Strawberry Fields now holds long-term leasehold interests in 142 facilities and more than 15,500 licensed beds, representing roughly 1% of U.S. nursing home capacity. This growth aligns with a broader demographic trend: the U.S. elderly care market, valued at $49.29 billion in 2024, is projected to nearly double to $98.19 billion by 2032 (https://ibn.fm/dgMsV).

While the company has grown its geographic footprint, which today spans Indiana, Illinois, Arkansas, Tennessee, Kansas, Kentucky, Missouri, Ohio, Oklahoma, and Texas, Gubin emphasized that expansion has been steady rather than hurried. He described reviewing roughly 300 potential acquisitions each year, submitting offers on a fraction, and ultimately closing five to ten properties annually. According to Gubin, the limiting factor is discipline, not access to capital.

A notable feature of the company’s approach is the use of master leases by geography. Rather than lease each building individually, Strawberry Fields groups properties into larger portfolios for one or two operators in each state. Gubin explained that this reduces risk: tenants cannot “cherry-pick” preferred facilities, and the performance of the portfolio as a whole supports rent coverage. This structure has contributed to the company’s record of collecting 100% of rents for seven to eight consecutive years.

The company’s leases typically begin at a 10% unlevered return, with 3% annual increases. The company targets an effective, levered, return of around 17% over time. Because rent levels are fixed rather than indexed to operator performance, rental income remains consistent regardless of operational variability at the tenant level.

At NobleCon21, Gubin reiterated that the company evaluates each property “as if we were the operator,” even though it remains strictly a landlord. He stressed that integrity, operational experience, and financial stability are the criteria he considers when selecting tenants. These tenant relationships often extend beyond formal asset management, with Gubin himself maintaining regular direct communication.

The presentation also highlighted portfolio diversification. While the company began with concentration in two states and a single tenant group, today the tenant base spans multiple independent operators in ten states.

Financial performance has remained a central element of the company’s message. For the third quarter of fiscal year 2025, Strawberry Fields reported rental income of $39.7 million, up $6.6 million from the prior year, driven by recent acquisitions in Missouri and Oklahoma. Funds From Operations rose to $20.7 million from $15.2 million in 2024, while Adjusted FFO expanded to $18.1 million from $14.3  million. Net income increased to $8.9 million to $6.9 million during the same period (https://ibn.fm/2TbZV).

The company maintains a payout ratio of roughly 47%, which Gubin said is intentionally conservative. Retained cash flow is deployed toward additional acquisitions, supporting the AFFO growth he sees as a key differentiator relative to REITs that distribute nearly all free cash.

Strawberry Fields reports approximately $1.1 billion in assets, at historical cost, and a market capitalization of about $750 million. Its debt mix includes long-duration HUD financing, Israeli bond issuances, and conventional debt. Gubin said a future step for the company is to secure a traditional unsecured line of credit, a feature common among large REITs and one he believes may help align market perception with available liquidity.

For investors tracking the senior housing and skilled nursing segments, Strawberry Fields presents a REIT model built on long-term leases, consistent rent collection, and measured expansion. The company’s approach avoids development exposure and operational risk, focusing instead on cash-flow stability in a sector expected to expand steadily over the next decade. Strawberry Fields is positioning its portfolio to meet rising demand through continued disciplined acquisition and tenant-focused underwriting, a strategy Gubin describes as central to both the company’s current performance and its long-term trajectory.

For more information, visit the company’s website at www.StrawberryFieldsREIT.com.

NOTE TO INVESTORS: The latest news and updates relating to STRW are available in the company’s newsroom at https://ibn.fm/STRW

• A central pillar of Search Mineral’s commitment to the community is its long-standing partnership with the NunatuKavut Community Council
• The company further reinforces this partnership through its governance structure
• Search Minerals also maintains frequent dialogue with leaders in St. Lewis, Mary’s Harbour and Port Hope Simpson

Disseminated on behalf of Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) and may include paid advertising.

Search Minerals (TSX.V: SMY) (OTC: SHCMF) is advancing rare earth development in Labrador with a strong focus on community partnership, Indigenous engagement and responsible long-term stewardship. As the company advances work across its Critical Rare Earth Element (“CREE”) Districts, it is committed to the principle that technical advancement must move in step with meaningful relationships. 

Search Minerals has built this foundation by collaborating closely with the NunatuKavut Community Council, inviting Indigenous leadership into its boardroom and maintaining open dialogue with municipal leaders in nearby communities. This collaborative model shapes environmental assessments, land-use planning and community engagement, underscoring the company’s commitment to ethical development and a durable social license.

A central pillar of that commitment is the company’s long-standing partnership with the NunatuKavut Community Council, which represents many Indigenous communities in southern and central Labrador. Search Minerals and NunatuKavut first entered a collaboration agreement in 2012 to guide communication, consultation processes and shared planning. Their renewed agreement, announced in 2021, strengthens this cooperative framework and outlines commitments related to project monitoring, employment pathways and culturally informed decision-making. 

The company further reinforces this partnership through its governance structure. Search Minerals appointed NunatuKavut representative Diane Poole to its board of directors, integrating Indigenous leadership directly into strategic oversight. Her involvement provides an essential perspective on cultural considerations, community priorities and collaborative development practices. Her appointment highlights the importance of Indigenous representation within corporate decision-making.  

These relationships guide the company’s plans as it advances environmental and technical studies for the Foxtrot and Deep Fox deposits. Search Minerals continues to refine its development model using its patented direct extraction technology, designed to reduce emissions, lower chemical use and minimize waste relative to traditional rare earth processing methods. By linking improved environmental performance with strong community relationships, the company aims to align its projects with both global supply chain needs and local sustainability expectations.

Search Minerals also maintains frequent dialogue with leaders in St. Lewis, Mary’s Harbour and Port Hope Simpson, three communities located near its exploration and development activities. Municipal consultations allow residents and officials to share priorities related to land use, environmental protection, economic development and long-term regional planning. These discussions help ensure that communities have a meaningful voice in shaping how rare earth development evolves in their region. 

These engagements directly influence the preparation of environmental assessments and regulatory filings. By incorporating feedback from NunatuKavut and local municipalities, Search Minerals works to ensure that baseline studies, cultural resource reviews, wildlife considerations and mitigation proposals reflect both regulatory expectations and community values. This approach strengthens transparency and helps build a durable social license as the company moves through successive stages of exploration and permitting.

Search Minerals has also outlined its commitment to creating long-term benefits for the region. The company has identified potential opportunities for local employment, training, business partnerships and community investment aligned with responsible resource development. These commitments complement broader provincial and federal goals to develop domestic critical minerals supply chain. The government of Canada has emphasized the importance of rare earth production within its national critical minerals strategy and has previously invested in technology development supporting REE.

As global demand for rare earth elements continues to rise, Search Minerals is positioning its Labrador district as a responsible contributor to the North American supply chain. By integrating Indigenous leadership, community consultation and environmental stewardship into every stage of its planning, the company demonstrates that ethical development and critical mineral production can advance together. Its collaborative approach strengthens trust, enhances transparency and reinforces the social foundations necessary for long-term success in Labrador.

For more information, visit the company’s website at https://searchminerals.ca.

NOTE TO INVESTORS: The latest news and updates relating to SHCMF are available in the company’s newsroom at https://ibn.fm/SHCMF

• Director Michael Blisko’s open-market share purchase signals ongoing insider confidence in OptimumBank’s outlook.
• The Bank posted its strongest quarter on record in Q3 2025, with net earnings of $4.32 million and ROE of about 22.6%.
• Net interest margin expanded to 4.37%, supported by higher-yielding loans and disciplined funding costs.
• Assets topped $1.08 billion and deposits approached $960 million, extending multi-year growth trends.
• Management continues to emphasize relationship banking and selective expansion across South Florida.

OptimumBank Holdings (NYSE American: OPHC), a community and business bank serving Florida, entered the final quarter of 2025 with a visible signal of internal confidence and a set of financial results that place it among the stronger performers in the U.S. community banking sector. The company disclosed earlier this month that Director Michael Blisko purchased additional shares of OptimumBank stock in the open market, a move that coincided closely with management’s characterization of the third quarter as the strongest in the Bank’s history.

According to a Form 4 filing, Blisko acquired 7,600 shares at an average price of $4.09, for a total investment of roughly $31,000 (https://ibn.fm/EIiIa). Insider purchases are closely watched by investors, particularly in smaller financial institutions, as they often reflect directors’ conviction in the sustainability of earnings and balance sheet strength. In this case, the transaction followed a quarter in which OptimumBank delivered record profitability and continued balance sheet expansion.

Headquartered in Fort Lauderdale, Florida, OptimumBank Holdings is a one-bank holding company that owns 100% of OptimumBank, a relationship-driven financial institution serving business and consumer clients both within Florida and beyond. Founded in 2000, the bank has built its franchise around personalized, high-touch banking, combining deep community roots with the ability to support clients across multiple markets without sacrificing service or discipline.

In the third quarter of 2025, OptimumBank reported net earnings of $4.32 million, or $0.37 per basic share, compared with $3.60 million in the prior quarter and $3.30 million in the year-earlier period (https://ibn.fm/WVxp9). For the first nine months of the year, net earnings reached $11.8 million, up from $9.17 million during the same period in 2024.

Net interest income was a primary driver. It rose to $11.05 million in the quarter, an increase of $810,000 from Q2 and more than $2 million from Q3 2024. Management attributed the improvement to higher yields on loans and other earning assets, coupled with stable funding costs as older, lower-rate loans rolled off the balance sheet.

That dynamic pushed OptimumBank’s net interest margin to 4.37% in the quarter, up five basis points sequentially and ahead of the 4.24% year-to-date margin reported earlier in the year. During the Q3 earnings call, executives noted that new loan originations are being booked at higher rates while efforts to reduce interest expense continue, supporting margin expansion (https://ibn.fm/bsg8Y).

Balance sheet growth has remained brisk. Total assets increased by nearly $84 million during the quarter to $1.08 billion, representing an annualized growth rate of roughly 34%. Deposits rose by $80.6 million to $959.5 million, a 9.17% quarter-over-quarter increase and nearly 37% on an annualized basis. Since the third quarter of 2024, deposits have grown by approximately $153 million.

Significantly for a community bank operating in a competitive rate environment, a meaningful portion of that funding remains relationship-based. Core noninterest-bearing demand deposits increased by more than $54 million during the quarter to about $314 million. The bank reported no borrowings in Q3, underscoring the strength of its deposit franchise.

Loan growth has been led by commercial real estate. Gross loans increased by $29.2 million in the quarter to $813.7 million, with commercial real estate balances rising by $46.6 million. Consumer loans also grew modestly, while land and construction loans declined as projects transitioned into permanent financing and management moderated exposure.

Capital strength remains a central theme. Total stockholders’ equity increased to $116.9 million at September 30, 2025, and the Tier 1 capital-to-assets ratio stood at 11.71%, well above the regulatory minimum. During the earnings call, management indicated that this capital position provides flexibility to pursue organic growth and consider mergers and acquisitions if opportunities align with the Bank’s strategy.

Chairman Moishe Gubin framed the results within the context of OptimumBank’s 25th anniversary, pointing to disciplined deposit pricing, targeted lending, and operational focus as drivers of performance. He has also emphasized the Bank’s community orientation, noting in a recent interview that OptimumBank is highly competitive based upon strong customer service and long-term relationships.

“Our momentum continues to build as we expand our customer base, strengthen our core earnings, and deliver meaningful value to our shareholders. Despite ongoing industry headwinds, our team’s disciplined approach to deposit pricing, targeted lending, and operating efficiency continues to drive results. With a growing foundation of loyal customers and a well-capitalized balance sheet, we are entering our next chapter with confidence, agility, and excitement for the opportunities ahead,” Gubin said.

For more information, visit the Bank’s website at www.OptimumBank.com.

NOTE TO INVESTORS: The latest news and updates relating to OPHC are available in the company’s newsroom at https://ibn.fm/OPHC